Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms
Abstract
Background
There
is growing evidence that natural products, mostly plant-derived
polyphenols, are important in the relationship between nutrients and
health in humans.
Purpose
We
aimed to investigate if verbascoside (VB) and other lemon verbena
polyphenols could ameliorate obesity-induced metabolic disturbances, as
well as their putative mechanism.
Study design
We
used an insulin-resistant hypertrophic 3T3-L1-adipocyte model to test
the effects of VB or lemon verbena extract on triglyceride accumulation,
inflammation and oxidative stress and a murine model of diet-induced
obesity to assess the in vivo metabolic response.
Results
Polyphenols
decreased triglyceride accumulation, the generation of reactive oxygen
species (ROS) and restored mitochondrial membrane potential in
adipocytes. The underlying mechanisms seemed to occur via ROS-mediated
downregulation of nuclear factor kappa-B transcription factor (NF-κB)
and peroxisome proliferator-activated receptor gamma (PPAR-γ)-dependent
transcriptional upregulation of adiponectin. We also observed a potent
activation of AMP-activated protein kinase (AMPK), the mRNA expression
upregulation of PPAR-α and the mRNA expression downregulation of fatty
acid synthase. Experiments in mice suggested a significant improvement
in fat metabolism.
Conclusion
Decreased
lipogenesis, enhanced fatty acid oxidation and the activation of the
energy sensor AMPK, probably through activating transcriptional factors,
are involved in the observed beneficial effects. VB effects were less
potent than those observed with the extract, so a potential synergistic,
multi-targeted action is proposed. The polypharmacological effects of
plant-derived polyphenols from lemon verbena may have the potential for
clinical applications in obesity.
Keywords
- Verbascoside;
- Lippia citriodora;
- Adipocyte;
- Adiponectin;
- AMPK;
- Fat metabolism
Abbreviations
- LC, Lippia citriodora extract;
- VB, verbascoside;
- FBS, fetal bovine serum;
- IBMX, 3-isobutyl-1-methylxanthine;
- DEX, dexamethasone;
- NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells;
- AMPK, adenosine monophosphate-activated protein kinase;
- CCL2, chemokine [C–C motif] ligand 2;
- TNF-α, tumor necrosis factor-alpha;
- IL-1α, interleukin-1 alpha;
- IL-1β, interleukin-1 beta;
- IL-6, interleukin 6;
- PPAR-γ, peroxisome proliferator-activated receptor gamma;
- CCL2/MCP-1, monocyte chemotactic protein-1;
- HF, high-fat, high-cholesterol diet;
- LDLr−/−, low density lipoprotein receptor knock-out mice;
- PPAR-α, peroxisome proliferator-activated receptor α;
- FASN, fatty acid synthase;
- FFAs, free fatty acids;
- TG, triglycerides;
- ROS, reactive oxygen species;
- AST, aspartate aminotransferase
Copyright © 2015 Elsevier GmbH. All rights reserved.